| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.3M | +63.3% |
| SG&A Expense | $13.2M | +31.9% |
| Operating Income | -$43.6M | -52.3% |
| Income Tax | $0 | — |
| Net Income | -$21.4M | -82.6% |
| EPS (Basic) | -$0.91 | +70.9% |
| EPS (Diluted) | -$0.91 | +70.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.6M | -24.0% |
| Current Assets | $47.6M | -19.2% |
| Total Assets | $50.4M | -14.7% |
| Current Liabilities | $7.8M | -0.9% |
| Total Liabilities | $10.2M | +29.4% |
| Stockholders' Equity | $40.2M | -21.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.5M | -410.4% |
| Capital Expenditures | $171K | +533.3% |
| Investing Cash Flow | -$171K | -533.3% |
| Financing Cash Flow | $5.5M | -89.6% |
| Free Cash Flow | -$18.7M | -411.3% |